After Hours
$
9.42
Change
+0.19 +2.06%
Volume
Volume 4,018
Feb 2, 2023, 4:42 p.m.
Quotes are delayed by 20 min
Previous close
$ 9.16
$ 9.23
Change
+0.07 +0.76%
Day low
Day high
$8.92
$9.35

52 week low
52 week high
$5.82
$20.40

Market cap
$373.32M
Average volume
168,580
P/E ratio
N/A
Rev. per Employee
N/A
EPS
-2.98
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on ALXO
-
ALX Oncology stock price target cut to $16 from $35 at Stifel Nicolaus
- Tomi Kilgore
-
ALX Oncology stock price target cut to $36 from $60 at Stifel Nicolaus
- Tomi Kilgore
-
ALX Oncology initiated at buy with $106 target price at Stifel
- Tonya Garcia
-
ALX Oncology started at buy with $96 stock price target at UBS
- Tomi Kilgore
-
Biotech stocks are a buy — especially these 18 picks
- Michael Brush
-
ALX Oncology sets IPO terms, to raise up to $136 million
- Tomi Kilgore
Other News on ALXO
-
10-Q: ALX ONCOLOGY HOLDINGS INC
- Edgar Online - (EDG = 10Q, 10K)
-
ALX Oncology (ALXO) Investor Presentation - Slideshow
- Seeking Alpha
-
Monster Moves Among Russell 3,000 Stocks
- Seeking Alpha
-
10-Q: ALX ONCOLOGY HOLDINGS INC
- Edgar Online - (EDG = 10Q, 10K)
-
ALX Oncology files for $450 mixed shelf offering
- Seeking Alpha
-
10-K: ALX ONCOLOGY HOLDINGS INC
- Edgar Online - (EDG = 10Q, 10K)
-
ALX Oncology Is Turning Into An Also-Ran In Anti-CD47
- Seeking Alpha
-
New Strong Sell Stocks for January 19th
- Zacks.com
-
ALX Oncology plunges as director sells shares worth $75M
- Seeking Alpha
- Loading more headlines...
Press Releases on ALXO
-
ALX Oncology Appoints Scott Garland to its Board of Directors
- GlobeNewswire
-
ALX Oncology Announces Evorpacept Clinical Program Updates
- GlobeNewswire
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com